US Broker Ratings

U.S. Physical Therapy, Inc. (USPH): Investor Outlook Highlights 25% Potential Upside

U.S. Physical Therapy, Inc. (NYSE: USPH), a prominent player in the healthcare sector specializing in medical care facilities, presents an intriguing investment opportunity for those seeking exposure to the healthcare..

Vera Therapeutics, Inc. (VERA)

⚠️ No article content returned.

..

Azenta, Inc. (AZTA) Stock Analysis: Understanding the 7.28% Potential Upside

Azenta, Inc. (AZTA), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, has caught the eye of investors with its intriguing financial landscape. As..

Kestra Medical Technologies (KMTS): Investor Outlook and Growth Potential with a 51.43% Upside

Kestra Medical Technologies, Ltd. (KMTS) is carving out a significant niche in the healthcare sector, specifically within the medical instruments and supplies industry. Founded in 2014 and headquartered in Kirkland,..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a 9.51% Potential Upside and Robust Product Portfolio

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a prominent player in the healthcare sector, is garnering attention from investors due to its dynamic product offerings and promising potential upside. With a market..

BioLife Solutions, Inc. (BLFS) Stock Analysis: 22.03% Potential Upside Could Entice Investors

BioLife Solutions, Inc. (BLFS), a key player in the healthcare sector, specifically within the medical instruments and supplies industry, is capturing investor attention with a promising potential upside of 22.03%...

10x Genomics, Inc. (TXG) Stock Analysis: Navigating the Healthcare Sector with a 12.9% Revenue Growth

10x Genomics, Inc. (NASDAQ: TXG), a prominent player in the healthcare sector, specializes in developing and marketing advanced life science technologies. With a market capitalization of $1.75 billion, the company..

Viridian Therapeutics, Inc. (VRDN) Investor Outlook: Exploring the 106.79% Potential Upside

Investors eyeing the biotechnology sector might want to turn their attention to Viridian Therapeutics, Inc. (VRDN), a promising player with a focus on developing treatments for serious and rare diseases...

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Biotech Innovator with a 145.93% Potential Upside

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is capturing investors’ attention with its promising 145.93% potential upside, making it a compelling choice in the burgeoning biotechnology sector. As a clinical-stage biopharmaceutical company..

The Pennant Group, Inc. (PNTG) Stock Analysis: Healthcare Sector’s Potential with 36% Upside

The Pennant Group, Inc. (NASDAQ: PNTG), a prominent player in the healthcare sector, particularly in the Medical Care Facilities industry, is catching the attention of savvy investors. With a market..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Exploring a 39% Potential Upside

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a burgeoning player in the biopharmaceutical landscape, is rapidly gaining attention among investors driven by its focus on dermatological treatments. With a current market cap..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: A Promising 90% Upside Potential in the Precision Medicine Space

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is making significant strides in the biotechnology sector with its focus on precision medicine oncology. With a market capitalization of $2.17 billion, the company is..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a 33% Upside Potential in Bioelectric Medicine

Pulse Biosciences, Inc (NASDAQ: PLSE), an innovative player in the healthcare sector, is making waves with its cutting-edge bioelectric medicine technology. With a market capitalization of $1.11 billion, the company..

Dynavax Technologies (DVAX) Investor Outlook: Analyzing the 119% Potential Upside

Dynavax Technologies Corporation (NASDAQ: DVAX), a promising player in the healthcare sector, offers intriguing prospects for investors with a potential upside of 119.44%. With a market capitalization of $1.22 billion,..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Evaluating the 9.75% Potential Upside for Investors

Healthcare Services Group, Inc. (NASDAQ: HCSG) is a prominent player in the healthcare sector, specifically within the medical care facilities industry. With a focus on providing essential services to the..

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: Examining a 37.25% Upside Potential Amidst Solid Buy Ratings

Acadia Healthcare Company, Inc. (NASDAQ: ACHC), a prominent player in the healthcare sector, specifically within medical care facilities, is capturing investor attention with significant growth potential. Based in Franklin, Tennessee,..

Liquidia Corporation (LQDA): Investor Outlook on a Biotech with 39.68% Potential Upside

Liquidia Corporation (NASDAQ: LQDA), a promising biopharmaceutical entity in the biotechnology sector, is capturing investor attention with its significant potential upside of 39.68%. Headquartered in Morrisville, North Carolina, Liquidia is..

Bausch Health Companies Inc. (BHC) Stock Analysis: Navigating Challenges with Strategic Diversification

Investors in Bausch Health Companies Inc. (NYSE: BHC) find themselves at a crossroads as the company presents a mixed bag of financial metrics and growth opportunities. With a market cap..

Immunovant, Inc. (IMVT) Stock Analysis: A 165% Upside Potential in the Biotech Arena

Immunovant, Inc. (IMVT), a clinical-stage immunology company, is drawing significant attention from investors with its recent stock analysis suggesting a substantial upside potential. With a market capitalization of $2.6 billion..

Evolent Health (EVH) Stock Analysis: Exploring a 57.81% Potential Upside in the Health Information Services Sector

Evolent Health, Inc. (NYSE: EVH) stands as a prominent player in the healthcare sector, specifically within the health information services industry. Based in Arlington, Virginia, Evolent Health leverages its expertise..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds